2F: Bridging Science and Market: Commercial Pathways for Biomaterials

Date: Wednesday, March 25, 2026
Time: 3:45 PM to 5:15 PM

Room: Hanover FG

Session Type: Concurrent Session 2

Description

Post-market commercialization pathways for advanced biomaterial technologies
How biomaterial biocompatibility shapes clinical performance and long-term commercial value
Lessons learned in scalable manufacturing, quality control, validation, analytical troubleshooting, failure analysis, and reproducibility

3:45 PM. 84. Commercializing a Class III Medical Device: Lessons Learned with AeroVeil.Lauren Costella, ME1, Kate Johnson1, Christopher Tison, PhD1 1Luna Labs USA
4:15 PM. 86. Hybrid Fiber Meshes for Soft Tissue Reinforcement, Repair, and Regeneration in Breast Reconstruction.Shatil Shahriar1, Jingwei Xie1 1University of Nebraska Medical Center
4:30 PM. 87. Failure Analysis of Hydrogels: Case Studies in the Biomedical Space.Abigail Oelker1, Mike Kratochvil1, Naomi Clayman1, Jessica Vargas1 1Exponent
4:45 PM. 88. Innovative Silicone Rubber Compositions with Anti-Biofilm Characteristics for Preventing Medical Device Infections.David Vachon, Ph.D.1, Mark Vachon, B.S.1 1IASIS Molecular Sciences, Inc.

2F: Bridging Science and Market: Commercial Pathways for Biomaterials

Description

3:45 PM. 84. Commercializing a Class III Medical Device: Lessons Learned with AeroVeil.Lauren Costella, ME1, Kate Johnson1, Christopher Tison, PhD1 1Luna Labs USA

4:15 PM. 86. Hybrid Fiber Meshes for Soft Tissue Reinforcement, Repair, and Regeneration in Breast Reconstruction.Shatil Shahriar1, Jingwei Xie1 1University of Nebraska Medical Center

4:30 PM. 87. Failure Analysis of Hydrogels: Case Studies in the Biomedical Space.Abigail Oelker1, Mike Kratochvil1, Naomi Clayman1, Jessica Vargas1 1Exponent

4:45 PM. 88. Innovative Silicone Rubber Compositions with Anti-Biofilm Characteristics for Preventing Medical Device Infections.David Vachon, Ph.D.1, Mark Vachon, B.S.1 1IASIS Molecular Sciences, Inc.